Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002386352 | SCV002692871 | likely benign | Cardiovascular phenotype | 2020-02-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV002535544 | SCV003483747 | likely benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2025-02-01 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004711302 | SCV005262648 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV004711302 | SCV005624789 | uncertain significance | not provided | 2023-10-12 | criteria provided, single submitter | clinical testing |